These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28860222)

  • 1. Variability in Total Cholesterol Is Associated With the Risk of End-Stage Renal Disease: A Nationwide Population-Based Study.
    Kim MK; Han K; Koh ES; Kim HS; Kwon HS; Park YM; Yoon KH; Lee SH
    Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1963-1970. PubMed ID: 28860222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-individual variability in high density lipoprotein cholesterol and risk of end-stage renal disease: A nationwide population-based study.
    Koh ES; Kim M; Kim MK; Han K; Shin SJ; Kwon HS; Park CW; Park YG; Chung S
    Atherosclerosis; 2019 Jul; 286():135-141. PubMed ID: 31158787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease.
    Bae EH; Lim SY; Han KD; Oh TR; Choi HS; Kim CS; Ma SK; Kim SW
    Hypertension; 2019 Oct; 74(4):880-887. PubMed ID: 31422691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Kim MK; Han K; Kim HS; Park YM; Kwon HS; Yoon KH; Lee SH
    Eur Heart J; 2017 Dec; 38(48):3560-3566. PubMed ID: 29069458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High remnant-cholesterol levels increase the risk for end-stage renal disease: a nationwide, population-based, cohort study.
    Jung HN; Huh JH; Roh E; Han KD; Kang JG; Lee SJ; Ihm SH
    Lipids Health Dis; 2024 Jun; 23(1):165. PubMed ID: 38835081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
    Kim MK; Han K; Park YM; Kwon HS; Kang G; Yoon KH; Lee SH
    Circulation; 2018 Dec; 138(23):2627-2637. PubMed ID: 30571256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total cholesterol variability and risk of atrial fibrillation: A nationwide population-based cohort study.
    Roh E; Chung HS; Lee JS; Kim JA; Lee YB; Hong SH; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
    PLoS One; 2019; 14(4):e0215687. PubMed ID: 31017966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructive sleep apnea as a risk factor for incident end stage renal disease: a nationwide population-based cohort study from Korea.
    Choi HS; Kim HY; Han KD; Jung JH; Kim CS; Bae EH; Ma SK; Kim SW
    Clin Exp Nephrol; 2019 Dec; 23(12):1391-1397. PubMed ID: 31468233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-glutamyl transferase variability can predict the development of end-stage of renal disease: a nationwide population-based study.
    Lee DY; Han K; Yu JH; Park S; Heo JI; Seo JA; Kim NH; Yoo HJ; Kim SG; Kim SM; Choi KM; Baik SH; Park YG; Kim NH
    Sci Rep; 2020 Jul; 10(1):11668. PubMed ID: 32669624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Variability in Blood Pressure, Glucose, and Cholesterol Concentrations, and Body Mass Index on End-Stage Renal Disease in the General Population of Korea.
    Kim MK; Han K; Kim HS; Park YM; Kwon HS; Yoon KH; Lee SH
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31137866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ideal cardiovascular health score and incident end-stage renal disease in a community-based longitudinal cohort study: the Kailuan Study.
    Han QL; Wu SL; Liu XX; An SS; Wu YT; Gao JS; Chen SH; Liu XK; Zhang Q; Mao RY; Shang XM; Jonas JB
    BMJ Open; 2016 Nov; 6(11):e012486. PubMed ID: 27899399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up.
    Pscheidt C; Nagel G; Zitt E; Kramar R; Concin H; Lhotta K
    PLoS One; 2015; 10(8):e0135052. PubMed ID: 26322515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in metabolic syndrome status affect the incidence of end-stage renal disease in the general population: a nationwide cohort study.
    Koh ES; Do Han K; Kim MK; Kim ES; Lee MK; Nam GE; Hong OK; Kwon HS
    Sci Rep; 2021 Jan; 11(1):1957. PubMed ID: 33479302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study.
    Lee SH; Kim HS; Park YM; Kwon HS; Yoon KH; Han K; Kim MK
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5633-5641. PubMed ID: 31408161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in Total Cholesterol Concentration Is Associated With the Risk of Dementia: A Nationwide Population-Based Cohort Study.
    Chung HS; Lee JS; Kim JA; Roh E; Lee YB; Hong SH; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
    Front Neurol; 2019; 10():441. PubMed ID: 31133961
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study.
    Jang YJ; Choy YS; Nam CM; Moon KT; Park EC
    BMC Nephrol; 2018 Jun; 19(1):127. PubMed ID: 29871604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the variability of blood pressure, glucose level, total cholesterol level, and body mass index on the risk of atrial fibrillation in a healthy population.
    Lee SR; Choi EK; Han KD; Lee SH; Oh S
    Heart Rhythm; 2020 Jan; 17(1):12-19. PubMed ID: 31299298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study.
    Park S; Chun J; Han KD; Soh H; Choi K; Kim JH; Lee J; Lee C; Im JP; Kim JS
    World J Gastroenterol; 2018 Nov; 24(42):4798-4808. PubMed ID: 30479466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visit-to-visit variability of metabolic parameters and risk of heart failure: A nationwide population-based study.
    Kwon S; Lee SR; Choi EK; Lee SH; Han KD; Lee SY; Yang S; Park J; Choi YJ; Lee HJ; Moon I; Lee E; Cha MJ; Lim WH; Oh S
    Int J Cardiol; 2019 Oct; 293():153-158. PubMed ID: 31253527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.